BRITTANY DENNISTON: Open Payments
NPI 1124395843 · FRANKFORT, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$785 in 41 payments from 12 companies in 2025. Trend: 2023 $782 · 2024 $1,767 · 2025 $785
Food & beverage: $785
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $290 |
| Novo Nordisk Inc | 8 | $200 |
| PFIZER INC. | 4 | $79 |
| GlaxoSmithKline, LLC. | 3 | $52 |
| Verona Pharma, Inc. | 1 | $28 |
| Alkermes, Inc. | 1 | $27 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Amgen Inc. | 1 | $16 |
Products named: QULIPTA, Ozempic, VRAYLAR, PREVNAR 20, TRELEGY ELLIPTA, Rybelsus, Ohtuvayre, VIVITROL.
Industry payments across KY — which companies pay providers there.
